FMR1 and fragile X syndrome: FMRP mRNA targets are involved in processes that occur during critical periods of postnatal neurodevelopment such as axonal guidance, synaptic connectivity, and neuronal network plasticity (Till, 2010) strongly suggesting that therapeutic intervention during these time windows could be relevant for completely or partially reversing the molecular and cellular alterations underlying the physiological symptoms observed in individuals with FXS.